Diabetes mellitus in der Koronarchirurgie

Literatur

• 1 Adler A I, Stratton I M, Neil H A, Yudkin J S, Matthews D R, Cull C A, Wright A D, Turner R C, Holman R R. Association of systolic blood pressure with macrovascular and microvascular complications of type 2 diabetes (UKPDS 36): prospective observational study.  BMJ. 2000;  321 412-419
• 2 Bourassa M G, Roubin G S, Detre K M, Sopko R J, Attabuto M J, Bjerregaad P, Bolling S, Herman M V, Frye R. and the BARI Study Group . Bypass Angioplasty Revascularization Inverstigation (BARI): patient screening, selection and recruitment.  Am J Cardiol. 1995;  75 3C-8C
• 3 Califf R M, Fortin D F, Frid D J, Harlan W R, Ohman E M, Bengtson J R, Nelson C L, Tcheng J E, Mark D B, Stack R S. Restenosis after coronary angioplasty: an overview.  J Am Coll Cardiol. 1991;  17 2B-13B
• 4 Caroza J P, Kuntz K E, Fishman R F, Baim D S. Restenosis after arterial injury caused by coronary stenting in patients with diabetes mellitus.  Ann Intern Med. 1993;  118 344-349
• 5 Chychota M N, Gan G T, Pluth J R, Wallace B, Danielson G K. Myocardial revascularization: comparison of operability and surgical results in diabetic and nondiabetic patients.  J Thorac Cardiovasc Surg. 1973;  65 856-862
• 6 Cohen R A, Vanhoutte P M. Endothelium-dependent hyperpolarization: beyond nitric oxide and cyclic GMP.  Circulation. 1995;  92 3337-3349
• 7 Engelmann R M, Bath J G, Glassmann E, Spencer F C, Boyd A D, Pasternak B S, Reed G E, Isom O W. The influence of diabetes and hypertension on the results of coronary revascularization.  Am J Cardiol (Abstract). 1975;  35 135
• 8 Furnary A P, Zerr K J, Grunkemeier G L, Starr A. Continuous intravenous insulin infusion reduces the incidence of deep sternal wound infection in diabetic patients after cardiac surgical procedures.  Ann Thorac Surg. 1999;  67 352-360
• 9 Jacoby R M, Nesto R W. Acute myocardial infarction in the diabetic patient: pathophysiology, clinical course and progress.  J Am Coll Cardiol. 1992;  20 7736-7744
• 10 Kip K, Faxon D, Detre K, Yeh W, Kelsey S F, Currier J W. Coronary angioplasty in diabetic patients (PTCA): The NHLBI PTCA Registry.  Circulation. 1996;  94 1818-1825
• 11 Nasher P J, Brown R E, Oskarrson H, Winniford M D, Rossen J. Maximal coronary flow reserve and metabolic coronary vasodilation in patients with diabetes mellitus.  Circulation. 1995;  91 635-640
• 12 Niles N W, McGrath P D, Malenka D, Quinton H, Wennberg D, Shubrooks S J, Tryzelaar J F, Clough R. et al. Northern New England Cardiovascular Disease Study Group . Survival of patients with diabetes and multivessel coronary artery disease after surgical or percutaneous revascularization: results of a large regional prospective study. Northern New England Cardiovascular Study Group.  J Am Coll Cardiol. 2001;  37 1016-1018
• 13 Protocoll for the Bypass Angioplasty Revascularization Investigation.  Circulation. 1991;  84 V1-V27 ((Suppl V))
• 14 Reaven G M. Role of insulin resistance in human disease.  Diabetes. 1988;  37 1595-1607
• 15 Rogers W J, Alderman R L, Chaitman B R, Di Sciascio G, Horan M, Lytle B, Mock M B, Rosen A D, Sutton-Tyrrel K, Weiner B H, Whitlow P L. and the BARI Study Group . Bypass Angioplasty Revascularization Investigation (BARI): baseline clinical and angiographic data.  Am J Cardiol. 1995;  75 9C-17C
• 16 Schaff H V, Rosen A D, Shemin R J, Leclerc Y, Wareing T H, Aguirre F V, Sopko G, Van der Salm T J, Loop F D. and the BARI Investigators . Clinical and operative characteristics of patients randomized to coronary artery bypass surgery in the Bypass Angioplasty Revascularization Investigation (BARI).  Am J Cardiol. 1995;  75 18c-26C
• 17 Stein B, Weintraub W S, Gebhart S P, Cohen-Bernstein C L, Groswald R, Liberman H A, Douglas J S, Morris D C, King S B. Influence of diabetes on early and late outcome after percutaneous transluminal coronary angioplasty.  Circulation. 1995;  91 979-989
• 18 The BARI Investigators . Comparison of coronary bypass surgery with angioplasty in patients with multivessel disease.  N Engl J Med. 1996;  335 217-225
• 19 The BARI Investigators . Influence of diabetes on 5-year mortality and morbidity in a randomized trial comparing CABG and PTCA in patients with multivessel disease.  Circulation. 1997;  96 1761-1769
• 20 The BARI Investigators . Seven-year outcome in the Bypass Angioplasty Revascularization Investigation (BARI) by treatment and diabetic status.  J Am Coll Cardiol. 2000;  35 1130-1133
• 21 Tomai F, Crea F, Gaspardon A, De Paulis R, Renta de Peppo A, Chiariello L, Giofre P. Ischemic preconditioning during coronary angioplasty is prevented by glibenclamid, a selective ATPase-sensitive K+channel blocker.  Circulation. 1994;  90 700-705
• 22 UK Prospective Diabetes Study Group . Tight blood pressure control and risk of macrovascular and microvascular complications in type 2 diabetes: UKPDS 38.  BMJ. 1998;  317 703-713
• 23 Verska J J, Waker W J. Aortocoronary bypass in the diabetic patient.  Am J Cardiol. 1975;  35 774-777
• 24 Wendler O, Hennen B, Markwirth T, Nikoloudakis N, Graeter T, Schafers H J. Complete arterial revascularization in the diabetic patient - early postoperative results.  Thorac Cardiovasc Surg. 2001;  49 5-9
• 25 Williams D O, Baim D S, Bates E, Bonan R, Bost J E, Cowley M, Faxon D P, Feit F, Jones R, Kellet M A, Kelsey S F, Sopko G, Stadius M, Topol E J. and the BARI Investigators . Coronary anatomic and procedural characteristics of patients randomized to coronary angioplasty in the Bypass Angioplasty Revascularization Investigation (BARI).  Am J Cardiol. 1995;  75 27C-33C
• 26 Zerr K J, Furnary A P, Grunkemeier G L, Bookin S, Kanhere V, Starr A. Glucose control lowers the risk of wound infection in diabetics after open heart operations.  Ann Thorac Surg. 1997;  63 356-361

Korrespondenz